OpenEvidence has raised a total of $300 million in funding over multiple rounds, achieving unicorn status in February 2025. Its latest Series B round of $210 million, closed on July 15, 2025, was led by Thrive Capital and Coatue. Founded in 2021 and headquartered in Cambridge, United States, OpenEvidence provides an AI-powered medical search platform for healthcare professionals, aggregating and visualizing clinical evidence to support informed decision-making. With 11–50 employees, the company continues to expand globally in the healthcare IT sector.